India records 16,906 new cases of COVID-19, active instances to 1,32,457 55 minutes ago
New strain of Omicron first noticed in India in May: WHO hours ago
Restart consciousness
The Unsung Hero of Holistic Recovery
Technological disruption in India and pharmacy
Are you up for the challenge?
Holistic solutions for a healthier India
July 17
Adopt dynamic technologies
More than 125,000 industry leaders read it every day
The developing anti-diabetic market, valued at around Rs 17 000 crore, is expected to see action with the launch of generic versions of US-based Merck’s blockbuster Januvia, reducing the cost of treatment by one third. major diabetes drug, which lost its patent coverage in July.
The use of antacids, which can cause abnormal heartbeat and plaque buildup in the arteries, increases the risk of developing cardiovascular disease in other people with GERD.